Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
European Journal of Immunology|November 1, 1983
Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigensN Flomenberg, K Naito, E Duffy, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotypeR W Knowles, N Flomenberg, K Horibe, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDSS E Krown, D Niedzwiecki, R B Bhalla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDSS E Krown, J Paredes, D Bundow, et al.Cellular Immunology|April 15, 1988
Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 moleculeC A Keever, E Benazzi, N A Kernan, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell linesK Horibe, N Flomenberg, M S Pollack, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4C A Keever, K Pekle, M V Gazzola, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiencyK Rosenkrantz, C Keever, K Bhimani, et al.Annals of Internal Medicine|June 1, 1990
Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)S E Krown, J W Gold, D Niedzwiecki, et al.British Journal of Haematology|July 1, 1983
ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentationR E Dinsmore, L M Reich, N Kapoor, et al.Pageof 11